MBA from Cornell University (US); Bachelor from Zhongshan University

Over 20 years of experience in multinational companies and the investment sector. Previously held senior positions at Syngenta, Eaton China, A.T.Kearney, General Electric, Philips and Shell.

Managing Director, CXC Capital

Senior VP, GL Capital

China Head, Olympus Capital                                                                               

Awards and Honors

Top 50 The Most Influential Investors, 2021 CHC China Healthcare Industry Investment and Financial Honor List

Top 100 Best Investors, 2021 Person of The Year by Qi Ming Pian

Top 10 Best Investors, 2021 Healthcare Investment by LP Club

Best Healthcare Investor, the 5th Healthcare Investment Excellent List by Haoyue Capital

Ascentage Pharma (6855.HK), Henlius Biotech (2696.HK), Kintor Pharma (9939.HK), Basecare Medical (2170.HK), BrightGene (688166), Allist Pharma (688578), Kawin Technology (688687), Nano-Micro (688690), YHLO Biotech (688575), ShengNuo Biotech (688117), Zylox-Tonbridge (2190.HK), Quantum-Si (NASDAQ), Creative Sciences, PegBio, Smartee, Capitalbio Technology, Innovita, Lifereal, Ark Biosciences, Jingfeng Pharma (000908), BGI Genomics (300676), Kangning Hospital (2120.HK) etc.